Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 10, Pages 2367-2384
http://dx.doi.org/10.1100/tsw.2010.230
Review Article

The Role of the TGF-β Coreceptor Endoglin in Cancer

1Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autênoma de Madrid, Madrid, Spain
2Institute for Medical Research, University of Belgrado, Belgrado, Serbia
3Instituto Reina Sofía de Investigaciên Nefrolêgica, Departamento de Fisiologia y Farmacología, Universidad de Salamanca, Salamanca, Spain
4Centro de Investigaciones Biológicas, CSIC, and CIBER de Enfermedades Raras (CIBERER), Madrid, Spain

Received 24 June 2010; Revised 4 November 2010; Accepted 16 November 2010

Academic Editor: Adele Murrell

Copyright © 2010 Eduardo Pérez-Gómez et al.

Citations to this Article [65 citations]

The following is the list of published articles that have cited the current article.

  • Juan F. Santibanez, Miguel Quintanilla, and Carmelo Bernabeu, “TGF-beta/TGF-beta receptor system and its role in physiological and pathological conditions,” Clinical Science, vol. 121, no. 5-6, pp. 233–251, 2011. View at Publisher · View at Google Scholar
  • Alan M. Holmes, Markella Ponticos, Xu Shi-Wen, Christopher P. Denton, and David J. Abraham, “Elevated CCN2 expression in scleroderma: A putative role for the TGFβ accessory receptors TGFβRIII and endoglin,” Journal of Cell Communication and Signaling, vol. 5, no. 3, pp. 173–177, 2011. View at Publisher · View at Google Scholar
  • Jana Rathouska, Lenka Vecerova, Zbynek Strasky, Martina Slanarova, Eva Brcakova, Zuzana Mullerova, Ctirad Andrys, Stanislav Micuda, and Petr Nachtigal, “Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis,” Pharmacological Research, vol. 64, no. 1, pp. 53–59, 2011. View at Publisher · View at Google Scholar
  • Yvette Drabsch, and Peter ten Dijke, “TGF-beta Signaling in Breast Cancer Cell Invasion and Bone Metastasis,” Journal of Mammary Gland Biology and Neoplasia, vol. 16, no. 2, pp. 97–108, 2011. View at Publisher · View at Google Scholar
  • Nataša Todorović-Raković, Jelena Milovanović, and Dragica Nikolić-Vukosavljević, “TGF-β and its coreceptors in cancerogenesis: an overview,” Biomarkers in Medicine, vol. 5, no. 6, pp. 855–863, 2011. View at Publisher · View at Google Scholar
  • Yukio Mano, Tomomi Kotani, Kiyozumi Shibata, Hiroko Matsumura, Hiroyuki Tsuda, Seiji Sumigama, Eiko Yamamoto, Akira Iwase, Takeshi Senga, and Fumitaka Kikkawa, “The Loss of Endoglin Promotes the Invasion of Extravillous Trophoblasts,” Endocrinology, vol. 152, no. 11, pp. 4386–4394, 2011. View at Publisher · View at Google Scholar
  • Magrone, and Jirillo, “The impact of bacterial lipolysaccharides on the endothelial system: Pathological consequences and therapeutic countermeasures,” Endocrine, Metabolic and Immune Disorders - Drug Targets, vol. 11, no. 4, pp. 310–325, 2011. View at Publisher · View at Google Scholar
  • David C. Budd, and Alan M. Holmes, “Targeting TGFβ superfamily ligand accessory proteins as novel therapeutics for chronic lung disorders,” Pharmacology & Therapeutics, vol. 135, no. 3, pp. 279–291, 2012. View at Publisher · View at Google Scholar
  • Petr Nachtigal, Lenka Zemankova (Vecerova), Jana Rathouska, and Zbynek Strasky, “The role of endoglin in atherosclerosis,” Atherosclerosis, vol. 224, no. 1, pp. 4–11, 2012. View at Publisher · View at Google Scholar
  • Henriett Butz, Károly Rácz, László Hunyady, and Attila Patócs, “Crosstalk between TGF-β signaling and the microRNA machinery,” Trends in Pharmacological Sciences, vol. 33, no. 7, pp. 382–393, 2012. View at Publisher · View at Google Scholar
  • Ping Liu, Yu-Lei Sun, Jie Du, Xiao-Sai Hou, and Hua Meng, “CD105/Ki67 Coexpression Correlates With Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer,” International Journal of Gynecological Cancer, vol. 22, no. 4, pp. 586–592, 2012. View at Publisher · View at Google Scholar
  • M Jarosz, J Jazowiecka-Rakus, T Cichoń, M Głowala-Kosińska, R Smolarczyk, A Smagur, S Malina, A Sochanik, and S Szala, “Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents,” Gene Therapy, vol. 20, no. 3, pp. 262–273, 2012. View at Publisher · View at Google Scholar
  • Adam D. Steg, Kerri S. Bevis, Ashwini A. Katre, Angela Ziebarth, Zachary C. Dobbin, Ronald D. Alvarez, Kui Zhang, Michael Conner, and Charles N. Landen, “Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer,” Clinical Cancer Research, vol. 18, no. 3, pp. 869–881, 2012. View at Publisher · View at Google Scholar
  • Sashidhar Nakerakanti, and Maria Trojanowska, “The role of TGF-β receptors in fibrosis,” Open Rheumatology Journal, vol. 6, no. 1, pp. 156–162, 2012. View at Publisher · View at Google Scholar
  • Eva W. Stratford, Russell Castro, Jeanette Daffinrud, Magne Skårn, Silje Lauvrak, Else Munthe, and Ola Myklebost, “Characterization of Liposarcoma Cell Lines for Preclinical and Biological Studies,” Sarcoma, vol. 2012, pp. 1–9, 2012. View at Publisher · View at Google Scholar
  • S Kumar, C C Pan, J C Bloodworth, A Nixon, C Theuer, D G Hoyt, and N Y Lee, “Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling,” Oncogene, 2013. View at Publisher · View at Google Scholar
  • Zaher I. Chakhachiro, Zhuang Zuo, Tariq N. Aladily, Hagop M. Kantarjian, Jorge E. Cortes, Khaled Alayed, Martin H. Nguyen, L. Jeffrey Medeiros, and Carlos Bueso-Ramos, “CD105 (endoglin) is highly overexpressed in a subset of cases of acute myeloid leukemias,” American Journal of Clinical Pathology, vol. 140, no. 3, pp. 370–378, 2013. View at Publisher · View at Google Scholar
  • Oujo, Perez-Barriocanal, Bernabeu, and Lopez-Novoa, “Membrane and soluble forms of endoglin in preeclampsia,” Current Molecular Medicine, vol. 13, no. 8, pp. 1345–1357, 2013. View at Publisher · View at Google Scholar
  • Michael J. Breen, Diarmuid M. Moran, Wenzhe Liu, Xiaoke Huang, Calvin P. H. Vary, and Raymond C. Bergan, “Endoglin-Mediated Suppression of Prostate Cancer Invasion Is Regulated by Activin and Bone Morphogenetic Protein Type II Receptors,” PLoS ONE, vol. 8, no. 8, 2013. View at Publisher · View at Google Scholar
  • Nusratuddin Abdullah, “Endoglin concentration in peritoneal fluid of patients with endometriosis,” Medical Journal of Indonesia, vol. 22, no. 2, pp. 88–91, 2013. View at Publisher · View at Google Scholar
  • Madelon Paauwe, Peter ten Dijke, and Lukas JAC Hawinkels, “Endoglin for tumor imaging and targeted cancer therapy,” Expert Opinion on Therapeutic Targets, vol. 17, no. 4, pp. 421–435, 2013. View at Publisher · View at Google Scholar
  • Ca Pappa, Mg Alexandrakis, A Boula, Fe Psarakis, A Kolovou, V Bantouna, E Stavroulaki, and G Tsirakis, “Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients,” Hematological Oncology, 2013. View at Publisher · View at Google Scholar
  • Da-Peng Feng, Quan Huang, Yan Li, Bi-Qiang Zheng, and Jian-Ru Xiao, “Biological characteristics of tumor stem cells from human osteosarcoma cell line MG-63,” Chinese Journal of Tissue Engineering Research, vol. 17, no. 10, pp. 1736–1741, 2013. View at Publisher · View at Google Scholar
  • C. Anderberg, S. I. Cunha, Z. Zhai, E. Cortez, E. Pardali, J. R. Johnson, M. Franco, M. Paez-Ribes, R. Cordiner, J. Fuxe, B. R. Johansson, M.-J. Goumans, O. Casanovas, P. ten Dijke, H. M. Arthur, and K. Pietras, “Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination,” Journal of Experimental Medicine, vol. 210, no. 3, pp. 563–579, 2013. View at Publisher · View at Google Scholar
  • Kenji Fujiwara, Kenoki Ohuchida, Takao Ohtsuka, Kazuhiro Mizumoto, Koji Shindo, Naoki Ikenaga, Lin Cui, Shunichi Takahata, Shinichi Aishima, and Masao Tanaka, “Migratory Activity of CD105+ Pancreatic Cancer Cells Is Strongly Enhanced by Pancreatic Stellate Cells,” Pancreas, vol. 42, no. 8, pp. 1283–1290, 2013. View at Publisher · View at Google Scholar
  • Orit Jacobson, and Xiaoyuan Chen, “Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics,” Pharmacological Reviews, vol. 65, no. 4, pp. 1214–1256, 2013. View at Publisher · View at Google Scholar
  • Angela J. Ziebarth, Somaira Nowsheen, Adam D. Steg, Monjri M. Shah, Ashwini A. Katre, Zachary C. Dobbin, Hee-Dong Han, Gabriel Lopez-Berestein, Anil K. Sood, Michael Conner, Eddy S. Yang, and Charles N. Landen, “Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer,” Clinical Cancer Research, vol. 19, no. 1, pp. 170–182, 2013. View at Publisher · View at Google Scholar
  • Daniel Beiroa, Amparo Romero-Picó, Carmen Langa, Carmelo Bernabeu, Miguel López, José M. López-Novoa, Ruben Nogueiras, and Carlos Diéguez, “Heterozygous Deficiency of Endoglin Decreases Insulin and Hepatic Triglyceride Levels during High Fat Diet,” PLoS ONE, vol. 8, no. 1, 2013. View at Publisher · View at Google Scholar
  • Michael G. Alexandrakis, and George Tsirakis, “Circulating levels of soluble angiogenic factors in multiple myeloma: Correlation with parameters of disease activity and prognosis,” Current Angiogenesis, vol. 2, no. 2, pp. 76–95, 2013. View at Publisher · View at Google Scholar
  • I Gomceli, M. Tez, E. B. Bostanci, A. S. Kemik, B. Demiriz, and M. Akoglu, “Prognostic significance of the preoperative serum levels of soluble form of endoglin in gastric cancer patients,” Bratislava Medical Journal-Bratislavske Lekarske Listy, vol. 114, no. 10, pp. 566–568, 2013. View at Publisher · View at Google Scholar
  • Edward J. Wladis, J. Andrew Carlson, Matthew S. Wang, Devang P. Bhoiwala, and Alejandro P. Adam, “Toll-Like Receptors and Vascular Markers in Ocular Rosacea,” Ophthalmic Plastic and Reconstructive Surgery, vol. 29, no. 4, pp. 290–293, 2013. View at Publisher · View at Google Scholar
  • Juan F. Santibanez, “Transforming Growth Factor-Beta and Urokinase-Type Plasminogen Activator: Dangerous Partners in Tumorigenesis—Implications in Skin Cancer,” ISRN Dermatology, vol. 2013, pp. 1–26, 2013. View at Publisher · View at Google Scholar
  • Christopher C. Pan, Sanjay Kumar, Nirav Shah, Dale G. Hoyt, Lukas J. A. C. Hawinkels, Karthikeyan Mythreye, and Nam Y. Lee, “Src-mediated Post-translational Regulation of Endoglin Stability and Function Is Critical for Angiogenesis,” Journal of Biological Chemistry, vol. 289, no. 37, pp. 25486–25496, 2014. View at Publisher · View at Google Scholar
  • Xiao-Ping Chen, You-Guo Chen, Jian-Yun Lan, and Zong-Ji Shen, “MicroRNA-370 suppresses proliferation and promotes endometrioid ovarian cancer chemosensitivity to cDDP by negatively regulating ENG,” Cancer Letters, 2014. View at Publisher · View at Google Scholar
  • Steffen K Meurer, Muhammad Alsamman, David Scholten, and Ralf Weiskirchen, “Endoglin in liver fibrogenesis: Bridging basic science and clinical practice.,” World journal of biological chemistry, vol. 5, no. 2, pp. 180–203, 2014. View at Publisher · View at Google Scholar
  • Takashi Inui, and Osamu Ishibashi, “Identification of endoglin-dependent BMP-2-induced genes in the murine periodontal ligament cell line PDL-L2,” Journal of Molecular Signaling, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Daniel Spadoto Dias, Flávia Neves Bueloni-Dias, Rogério Dias, Jorge Nahás-Neto, Eliana Aguiar Petri Nahás, Nilton José Leite, Maria Aparecida Custódio Domingues, Solange Peron Bueno Angela, and Carlos Roberto Padovani, “Usefulness of Clinical, Ultrasonographic, Hysteroscopic, and Immunohistochemical Parameters in Differentiating Endometrial Polyps From Endometrial Cancer,” Journal of Minimally Invasive Gynecology, vol. 21, no. 2, pp. 296–302, 2014. View at Publisher · View at Google Scholar
  • D. Salomon, “Transforming Growth Factor   in Cancer: Janus, the Two-Faced God,” JNCI Journal of the National Cancer Institute, vol. 106, no. 2, pp. djt441–djt441, 2014. View at Publisher · View at Google Scholar
  • G. del Castillo, E. Sanchez-Blanco, E. Martin-Villar, A. C. Valbuena-Diez, C. Langa, E. Perez-Gomez, J. Renart, C. Bernabeu, and M. Quintanilla, “Soluble endoglin antagonizes Met signaling in spindle carcinoma cells,” Carcinogenesis, vol. 36, no. 2, pp. 212–222, 2014. View at Publisher · View at Google Scholar
  • Jose M. Muñoz-Felix, Barbara Oujo, and Jose M. Lopez-Novoa, “The role of endoglin in kidney fibrosis,” Expert Reviews in Molecular Medicine, vol. 16, 2014. View at Publisher · View at Google Scholar
  • E. Núñez-Gómez, and J.M. Lopez-Novoa, “Papel de endoglina en los eventos fisiológicos involucrados en la revascularización postisquémica,” Angiología, 2014. View at Publisher · View at Google Scholar
  • Bin Liu, Wei Zhou, Xiaofeng Chen, Fengming Xu, Yinqin Chen, Jie Liu, Qingyu� Zhang, Shiting Bao, Nianping Chen, Mingyi Li, and Runzhi Zhu, “Dihydromyricetin induces mouse hepatoma Hepal‑6 cell apoptosis via the transforming growth factor‑β pathway,” Molecular Medicine Reports, 2014. View at Publisher · View at Google Scholar
  • Kristian Pietras, and Sara I. Cunhapp. 435–458, 2014. View at Publisher · View at Google Scholar
  • Christine W. Duarte, Kimberly Murray, F. Lee Lucas, Kathleen Fairfield, Heather Miller, Peter Brooks, and Calvin P. H. Vary, “Improved Survival Outcomes in Cancer Patients with Hereditary Hemorrhagic Telangiectasia,” Cancer Epidemiology Biomarkers & Prevention, vol. 23, no. 1, pp. 117–125, 2014. View at Publisher · View at Google Scholar
  • Adam Myszczyszyn, Anna M. Czarnecka, Damian Matak, Lukasz Szymanski, Fei Lian, Anna Kornakiewicz, Ewa Bartnik, Wojciech Kukwa, Claudine Kieda, and Cezary Szczylik, “The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis,” Stem Cell Reviews and Reports, 2015. View at Publisher · View at Google Scholar
  • Haizhou Liu, Shaoyang Wang, Weimin Ma, and Youguang Lu, “Transforming Growth Factor β1 Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells Via Up-Regulation of Connective Tissue Growth Factor,” Cell Biochemistry and Biophysics, 2015. View at Publisher · View at Google Scholar
  • Sunyoung Park, Christine M. Sorenson, and Nader Sheibani, “PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis,” Clinical Science, vol. 129, no. 3, pp. 217–234, 2015. View at Publisher · View at Google Scholar
  • Peiwu Li, Wangsheng Chen, Yingzhen Wang, Xu Fu, Kunming Wen, Jiang Qian, Chun Huang, and Zhongxue Fu, “Effects of ephrinB2 gene siRNA on the biological behavior of human colorectal cancer cells,” Oncology Reports, vol. 33, no. 2, pp. 758–766, 2015. View at Publisher · View at Google Scholar
  • Zeljko Martinovic, Drazen Kovac, and Mia Martinovic, “Prognostic Significance of Microvessel Density Determining by Endoglin in Stage II Rectal Carcinoma: A Retrospective Analysis,” Gastroenterology Research and Practice, vol. 2015, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  • Sarah E. Wheeler, and Nam Y. Lee, “Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy,” Journal of Cellular Physiology, 2016. View at Publisher · View at Google Scholar
  • Juan F Santibanez, Jelena Krstic, Miguel Quintanilla, and Carmelo BernabeueLS, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  • Hai-Rong Guo, Xiao-Yan Wang, Ping Liu, and Shuai He, “Impacts of RNAi silencing on the CD105 and Ki67 gene expression in ovarian cancer OVCAR3 cell lines,” Acta Anatomica Sinica, vol. 47, no. 4, pp. 502–506, 2016. View at Publisher · View at Google Scholar
  • Amal Fawzy, Tamer Elbaz, Eman Desouky, Salwa Teama, Shirin Teama, Amany Helal, and Amira Diyaa Drwish, “Increased serum endoglin and transforming growth factor β1 mRNA expression and risk of hepatocellular carcinoma in cirrhotic Egyptian patients,” Asian Pacific Journal of Cancer Prevention, vol. 17, no. 5, pp. 2429–2434, 2016. View at Publisher · View at Google Scholar
  • Željko Martinović, Dražen Kovač, and Cvita Martinović, “Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis,” World Journal of Surgical Oncology, vol. 14, no. 1, 2016. View at Publisher · View at Google Scholar
  • Kevin Gaston, Maria-Angela Tsitsilianos, Kerry Wadey, and Padma-Sheela Jayaraman, “Misregulation of the proline rich homeodomain (PRH/HHEX) protein in cancer cells and its consequences for tumour growth and invasion,” Cell And Bioscience, vol. 6, 2016. View at Publisher · View at Google Scholar
  • Kevin Gaston, Maria-Angela Tsitsilianos, Kerry Wadey, and Padma-Sheela Jayaraman, “Misregulation of the proline rich homeodomain (PRH/HHEX) protein in cancer cells and its consequences for tumour growth and invasion,” Cell & Bioscience, vol. 6, no. 1, 2016. View at Publisher · View at Google Scholar
  • Elena Núñez-Gómez, Miguel Pericacho, Claudia Ollauri-Ibáñez, Carmelo Bernabéu, and José M. López-Novoa, “The role of endoglin in post-ischemic revascularization,” Angiogenesis, 2016. View at Publisher · View at Google Scholar
  • M Paauwe, R C Heijkants, C H Oudt, G W van Pelt, C Cui, C P Theuer, J C H Hardwick, C F M Sier, and L J A C Hawinkels, “Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer,” Oncogene, 2016. View at Publisher · View at Google Scholar
  • Marcin Opławski, Andrzej Plewka, Mateusz Michalski, Bogdan Michalski, Maria Styblińska, Joanna Gola, Małgorzata Kasprzyk-Zyszczyńska, Urszula Mazurek, Andrzej Witek, Nikola Zmarzły, and Agnieszka Jȩda-Golonka, “Identification of a gene expression profile associated with the regulation of angiogenesis in endometrial cancer,” Molecular Medicine Reports, vol. 16, no. 3, pp. 2547–2555, 2017. View at Publisher · View at Google Scholar
  • Hongyu Tian, Tatiana Ketova, Duriel Hardy, Xiaojiang Xu, Xia Gao, Andries Zijlstra, and Gerard C. Blobe, “Endoglin Mediates Vascular Maturation by Promoting Vascular Smooth Muscle Cell Migration and Spreading,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 37, no. 6, pp. 1115–1126, 2017. View at Publisher · View at Google Scholar
  • Hikmet Gulsah Tanyildiz, Gulsah Kaygusuz, Emel Unal, Nurdan Tacyildiz, Handan Dincaslan, and Gulsan Yavuz, “The prognostic importance of TGF-β, TGF-β receptor, and fascin in childhood solid tumors,” Pediatric Hematology and Oncology, pp. 1–16, 2017. View at Publisher · View at Google Scholar
  • Michael Rose, Steffen K. Meurer, Vera Kloten, Ralf Weiskirchen, Bernd Denecke, Wiebke Antonopoulos, Martina Deckert, Ruth Knüchel, and Edgar Dahl, “ITIH5 induces a shift in TGF-β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death,” Molecular Carcinogenesis, 2017. View at Publisher · View at Google Scholar
  • Basavaraj Vastrad, Chanabasayya Vastrad, Anandkumar Tengli, and Sudhir Iliger, “Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis,” Archives of Gynecology and Obstetrics, 2017. View at Publisher · View at Google Scholar
  • Tomasz Szafarowski, Janusz Sierdzinski, Miroslaw J. Szczepanski, Theresa L. Whiteside, Nils Ludwig, and Antoni Krzeski, “Microvessel density in head and neck squamous cell carcinoma,” European Archives of Oto-Rhino-Laryngology, 2018. View at Publisher · View at Google Scholar
  • Weimin Ren, Lingyun Zhang, Guoxiong Xu, Jinguo Zhang, and Qunbo Lin, “Prognostic value of endoglin-assessed microvessel density in cancer patients: A systematic review and meta-analysis,” Oncotarget, vol. 9, no. 7, pp. 7660–7671, 2018. View at Publisher · View at Google Scholar